ASAHI INTECC USA Partners with QXMédical for Innovative Catheter Distribution

ASAHI INTECC USA Announces Exciting Distribution Agreement with QXMédical for Boosting Catheter

On May 4, 2026, ASAHI INTECC USA, Inc. officially reported the initiation of a distribution agreement with QXMédical to bring the Boosting Catheter into the U.S. market. This strategic collaboration highlights ASAHI INTECC's commitment to enhancing medical technology and providing advanced solutions for healthcare professionals.

The Boosting Catheter, designed with cutting-edge technology, has already garnered attention in select global markets and is set to make its mark in the United States. As minimally invasive procedures gain traction in treating various vascular complications, the Boosting Catheter is poised to support physicians effectively in coronary interventions, such as percutaneous coronary interventions (PCI) and chronic total occlusions (CTOs).

Joe Wright, General Manager at ASAHI INTECC USA, expressed enthusiasm for the new collaboration, stating, "The partnership with QXMédical demonstrates our commitment to equipping physicians with essential tools for advancing coronary interventions." He noted that the Boosting Catheter aligns perfectly with ASAHI's mission to provide healthcare professionals with a comprehensive suite of innovative technologies aimed at optimizing patient care and outcomes.

The Boosting Catheter is designed to serve as a guide extension for delivering interventional devices effectively within coronary vessels. With its unparalleled trackability and a unique atraumatic tip design, it ensures a smooth workflow during complex medical procedures. Its larger internal passageways accommodate a variety of interventional devices, making it an invaluable asset in any healthcare professional's toolkit. Additionally, the catheter is available in French sizes ranging from 5.5 to 8 and is the only guide extension that holds a clinical indication for the delivery of procedural fluids, enhancing its versatility in various medical contexts.

Fernando Di Caprio, President and Chief Technology Officer at QXMédical, emphasized the importance of this partnership in expanding their presence in the U.S. healthcare market. He remarked, "We are excited to bring the Boosting Catheter to the U.S. through our partnership with ASAHI INTECC USA. This collaboration marks a pivotal moment in our growth strategy, allowing us to directly connect with American physicians. By leveraging ASAHI's extensive network and their deep understanding of the coronary intervention landscape, we believe we can significantly enhance the availability of our innovative Boosting Catheter."

Continuing to highlight QXMédical's dedication to advancing medical technology, Di Caprio stated that this partnership reflects a shared vision to improve healthcare outcomes across the country. The Boosting Catheter, manufactured by QXMédical, is a testament to the company's commitment to providing physician-focused solutions for complex procedures worldwide.

With ASAHI INTECC’s experience in the development and distribution of medical devices and QXMédical’s focus on innovative advancements, this partnership promises to elevate the standards of care in the realm of cardiovascular and peripheral interventions. The collaboration represents a harmonious blend of expertise aimed at transforming the treatment landscape for patients with coronary artery disease.

Both companies are committed to pushing the boundaries of what is possible in medical technology, ensuring that healthcare professionals have access to the best tools available. This collaboration is just the beginning, as ASAHI INTECC USA and QXMédical continue to innovate and refine their products to meet the evolving needs of physicians and patients alike.

To learn more about ASAHI INTECC USA's medical offerings, please visit their website at asahi-inteccusa-medical.com.